Role of antidepressants in the treatment of adults with anorexia nervosa
Mental Health Clinician · 01.05.2018 · 8 (3) · 127-137
DOI: 10.9740/mhc.2018.05.127 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mental Health Clinician, erschienen am 01.05.2018. Verfasst von Marketa Marvanova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Associate Professor, Department of Pharmacy Practice, School of Pharmacy, College of Health Professions, North Dakota State University, Far…. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Anorexia nervosa (AN) is a severe psychiatric disorder that is difficult to treat and is associated with frequent relapses and high mortality rates. Psychiatric symptomatology (eg, depression, anxiety, obsessive-compulsive disorder/behaviors) are common comorbidities. This review provides current information about safety and efficacy of antidepressant therapy for management of AN in adults.
Methods
A literature review of randomized controlled trials, open-label studies, and case reports with adults or adults/adolescents was conducted. PubMed and Medline were searched using anorexia management and treatment, antidepressants, selective serotonin reuptake inhibitors (SSRIs), fluoxetine, sertraline, citalopram, and mirtazapine in AN, relapse prevention in AN, and psychotropic medications in AN.
Results
The role and utility of antidepressants in AN were published in double-blind, placebo-controlled studies; open-label trials; and a retrospective study. Antidepressants should not be used as sole therapy for AN although their use for confounding symptomatology makes discerning efficacy difficult as they are given together with other therapies. Neurobiological changes due to starvation and AN itself complicate results interpretation. For safety, tricyclic antidepressants and monoamine oxidase inhibitors are not recommended, and bupropion is contraindicated. Use of SSRIs during acute treatment lacks efficacy. Use of SSRIs—primarily fluoxetine and to some extent citalopram, sertraline, or mirtazapine—may aid in relapse prevention and improvement of psychiatric symptomatology in weight-restored anorexic patients.
Discussion
Health care professionals should use clinical judgment regarding fluoxetine or possibly citalopram, sertraline or mirtazapine as adjunctive treatment to psychotherapy for relapse prevention, improvement of depressive and anxiety symptoms, and/or obsessive-compulsive behaviors unresolved with nutritional rehabilitation and psychotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair and Associate Professor, Department of Pharmacy Practice, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, North Dakota, marketa.marvanova@ndsu.edu.
- PGY-1 Resident, University of Minnesota, Postgraduate Pharmacy Residency Program, Minneapolis, Minnesota.
ORCID-Profile: Marketa Marvanova, Kirstin Gramith
Zitieren
APA
Marvanova, M., & Gramith, K. (2018). Role of antidepressants in the treatment of adults with anorexia nervosa. Mental Health Clinician, 8(3), 127-137. https://doi.org/10.9740/mhc.2018.05.127
Vancouver
Marvanova M, Gramith K. Role of antidepressants in the treatment of adults with anorexia nervosa. Mental Health Clinician. 2018;8(3):127-137. doi:10.9740/mhc.2018.05.127
BibTeX
@article{Marvanova2018,
author = {Marvanova, Marketa and Gramith, Kirstin},
title = {Role of antidepressants in the treatment of adults with anorexia nervosa},
journal = {Mental Health Clinician},
year = {2018},
volume = {8},
number = {3},
pages = {127--137},
doi = {10.9740/mhc.2018.05.127}
}
EUVIMED